BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38377060)

  • 1. Comparison of postoperative complications in mediastinal lymph node dissection versus mediastinal lymph node sampling for early stage non-small cell lung cancer: Protocol for a systematic review and meta-analysis.
    Chen Q; Li W; Cai N; Chen W; Zhao X; Huang X
    PLoS One; 2024; 19(2):e0298368. PubMed ID: 38377060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediastinal lymph node dissection versus mediastinal lymph node sampling for early stage non-small cell lung cancer: a systematic review and meta-analysis.
    Huang X; Wang J; Chen Q; Jiang J
    PLoS One; 2014; 9(10):e109979. PubMed ID: 25296033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node dissection and survival in patients with early stage nonsmall cell lung cancer: A 10-year cohort study.
    Shen-Tu Y; Mao F; Pan Y; Wang W; Zhang L; Zhang H; Cheng B; Guo H; Wang Z
    Medicine (Baltimore); 2017 Oct; 96(43):e8356. PubMed ID: 29069017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediastinal lymph node dissection versus spared mediastinal lymph node dissection in stage IA non-small cell lung cancer presented as ground glass nodules: study protocol of a phase III, randomised, multicentre trial (MELDSIG) in China.
    Li C; Ni Y; Liu C; Liu R; Zhang C; Song Z; Liu H; Jiang T; Zhang Z
    BMJ Open; 2023 Oct; 13(10):e075242. PubMed ID: 37898488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome.
    Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK
    Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel node sampling limits lymphadenectomy in stage I non-small cell lung cancer.
    Muraoka M; Akamine S; Oka T; Tagawa T; Nakamura A; Tsuchiya T; Hayashi T; Nagayasu T
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):356-61. PubMed ID: 17513118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer.
    Zhong W; Yang X; Bai J; Yang J; Manegold C; Wu Y
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):187-95. PubMed ID: 18457958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lobe-Specific Node Dissection Can Be a Suitable Alternative to Systematic Lymph Node Dissection in Highly Selective Early-Stage Non-Small-Cell Lung Cancer Patients: A Meta-Analysis.
    Wang Z; Qi Z; Cheng D; Hao X; Pu Q; Liu L
    Ann Thorac Cardiovasc Surg; 2021 Jun; 27(3):143-150. PubMed ID: 33281131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparison of Lobe-Specific or Systematic Mediastinal Lymph Node Dissection for Early-Stage Lung Adenocarcinoma With Consolidation Tumor Ratio Over 0.5.
    Sui Q; Yang H; Yin J; Li M; Jin X; Chen Z; Jiang W; Wang Q
    Clin Lung Cancer; 2023 Jan; 24(1):51-59. PubMed ID: 36153194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Eastern Cooperative Oncology Group.
    Keller SM; Adak S; Wagner H; Johnson DH
    Ann Thorac Surg; 2000 Aug; 70(2):358-65; discussion 365-6. PubMed ID: 10969645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of Shenqi Fuzheng injection combined with platinum-based chemotherapy for stage III/IV non-small cell lung cancer: A protocol for systematic review and meta-analysis of randomized controlled trials.
    Chen H; Yao X; Liu Z; Li T; Xu C; Wang J; Sui X; Leung EL; Wu Q
    Medicine (Baltimore); 2019 Sep; 98(39):e17350. PubMed ID: 31574877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extent of Lymph Node Dissection in Patients with Small-Sized Peripheral Non-Small Cell Lung Cancer during Intentional Segmentectomy.
    Maniwa T; Ohue M; Shintani Y; Okami J
    Ann Thorac Cardiovasc Surg; 2023 Dec; 29(6):271-278. PubMed ID: 37100608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer.
    Gajra A; Newman N; Gamble GP; Kohman LJ; Graziano SL
    J Clin Oncol; 2003 Mar; 21(6):1029-34. PubMed ID: 12637467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete thoracic mediastinal lymphadenectomy leads to a higher rate of pathologically proven N2 disease in patients with non-small cell lung cancer.
    Cerfolio RJ; Bryant AS; Minnich DJ
    Ann Thorac Surg; 2012 Sep; 94(3):902-6. PubMed ID: 22776083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Shenmai injection combined with platinum-containing first-line chemotherapy on quality of life, immune function and prognosis of patients with nonsmall cell lung cancer: A protocol for systematic review and meta-analysis.
    Chen Y; Zhang C; Pan C; Yang Y; Liu J; Lv J; Pan G
    Medicine (Baltimore); 2021 Nov; 100(44):e27524. PubMed ID: 34871214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer].
    Pan TC; Zheng Z; Li J; Chen T; Liu LG; Wei X
    Ai Zheng; 2007 Mar; 26(3):303-6. PubMed ID: 17355796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LobE-Specific lymph node diSsectiON for clinical early-stage non-small cell lung cancer: protocol for a randomised controlled trial (the LESSON trial).
    Huang W; Deng HY; Ren ZZ; Xu K; Wang YF; Tang X; Zhu DX; Zhou Q
    BMJ Open; 2022 Aug; 12(8):e056043. PubMed ID: 36038163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mediastinal lymph nodes sampling in patients with clinical stage I non-small cell lung cancer.
    Takizawa H; Kondo K; Matsuoka H; Uyama K; Toba H; Kenzaki K; Sakiyama S; Tangoku A; Miura K; Yoshizawa K; Morita J
    J Med Invest; 2008 Feb; 55(1-2):37-43. PubMed ID: 18319543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
    Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
    Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.